A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementF. Xavier Pi‐Sunyer, John Wilding, Arne Astrup et al.|New England Journal of Medicine|2015Cited by 2.6k
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trialsRobin Christensen, Arne Astrup, Pernelle Kruse Kristensen et al.|The Lancet|2007Cited by 1.1k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, John Wilding et al.|The Lancet|2017Cited by 843
Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC)Livia S. A. Augustin, Andrea Poli, Cyril W.C. Kendall et al.|Nutrition Metabolism and Cardiovascular Diseases|2015Cited by 691
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?Arne Astrup, Walter C. Willett, Jørn Dyerberg et al.|American Journal of Clinical Nutrition|2011Cited by 490